MGX

Metagenomi (MGX)

About Metagenomi (MGX)

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Details

Daily high
$1.43
Daily low
$1.38
Price at open
$1.43
52 Week High
$3.95
52 Week Low
$1.25
Market cap
53.0M
Dividend yield
0.00%
Volume
957
Avg. volume
166,410
P/E ratio
-.60

Metagenomi News

Details

Daily high
$1.43
Daily low
$1.38
Price at open
$1.43
52 Week High
$3.95
52 Week Low
$1.25
Market cap
53.0M
Dividend yield
0.00%
Volume
957
Avg. volume
166,410
P/E ratio
-.60